NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
12/19/2023
Back to search
Official data from USPTO
NEUROCLUES
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
NEUROCLUES
ST13
US500000097241933Class
5, 9, 10, 42, 44
Filing
97241933
Registration
7245599
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
29
Latest update
12/19/2023
Trademark type
Word
Nice classes
5, 9, 10, 42, 44
Filing date
01/27/2022
Registration date
12/19/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/19/2023
Last transaction
12/19/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
03
Owner location
Louvain-laNeuve, BE
Examiner
LAVACHE, LINDA
Law office
L60
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
P³LAB
Representatives
Michael A. Grow ArentFox Schiff LLP
Technical classification
Nice Classes
Class 5Class 9Class 10Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for use in ophthalmology; Diagnostic preparations for medical use; Diagnostic preparations for medical purposes; Antiserums being diagnostic preparations for medical purposes; Diagnostic agents for medical use; Diagnostic agents for pharmaceutical use in treating and preventing neurological disorders and vision impairment and for brain health monitoring; Clinical diagnostic reagents for medical use; Reactants being diagnostic preparations for medical diagnosis; Pharmaceutical preparations for the treatment and prevention of neurological disorders and vision impairment and for brain health monitoring; Chemical preparations for medical purposesfor the treatment and prevention of neurological disorders and vision impairment and for brain health monitoring; Dermatological pharmaceutical products; Pharmaceuticals for the treatment and prevention of neurological disorders and vision impairment and for brain health monitoring; Chemico-pharmaceutical preparations for the treatment and prevention of neurological disorders and vision impairment and for brain health monitoring; Pharmaceutical products for ophthalmological use; Topical ophthalmic anti-infective substances for the treatment of infections; Diagnostic biomarker reagents for medical purposes
Class 9
Contact lenses; Optical enhancersoptical filters; Lasersnot for medical purposes; Optical inspection apparatus for industrial use; Optical target seekersoptical lens sights; Telescopic target seekerstelescopic lens sights; Apparatus and instruments for physicsoptical reflectorsoptical sensors; Optical apparatus and instrumentsoptical sensorsoptical readers; Eyewear; Optical filters; Optical glass filters; Teaching and instructional apparatusmedical diagnostic simulators for use as teaching aids for brain health monitoring; Biometric identification apparatus; Imaging devices for scientific purposesnuclear medical research imaging apparatus; Telescopes; Ultramicroscopes; Glassware for use in a laboratory; Specifically adapted glassware for scientific uselaboratory glassware; Optical lenses; Apparatusinstruments and cables for electricitytransformerselectric meterselectric cables; Scientific and laboratory devices for treatment using electricityelectricity distribution consoles; Optical devicesenhancers and correctorsoptical filtersoptical sensorsoptical readersoptical cables; Residual light image amplifiers; Thermal imaging apparatusother than for medical use; Stereoscopic apparatusstereoscopes; Observation instrumentscameras; Downloadable and recorded software for analyzing eye movement data; Downloadable and recorded adaptive software for converting eye-tracking data; Downloadable and recorded computer software for enabling the provision of electronic transmission of eye tracking data via communications networks; Interfaces for computers; Communication interface unitsComputer interface boards; Downloadable graphical user interface software; Downloadable computer software for use as an application programming interface (API)
Class 10
Ophthalmological instrumentseye testing apparatus; Therapeutic instruments for ophthalmologysensors for medical use to gather biometric data; Ophthalmological instrumentsIntraocular lens biometers; Pupillometers for measuring pupillary distance (PD); Pupillometers for measuring pupillary reactivity to stimulus; Ophthalmological instrumentsoptometric instruments for measuring the diameter of ophthalmic lenses; Apparatus for the diagnosis of neurological diseasesMRI apparatus for medical purposes; Lasers for medical use
Class 42
Providing temporary use of on-line non-downloadable software for the management of data; Providing information about the design and development of computer software; Providing temporary use of on-line non-downloadable software for the transmission of data; Providing temporary use of on-line non-downloadable software for database management; Providing temporary use of on-line non-downloadable operating software for accessing and using a cloud computing network
Class 44
Pharmaceutical advice; Medical diagnostic testingmonitoring and reporting services; Medical services; Performing diagnosis of diseases; Medical diagnostic servicesmedical diagnostic testingmonitoring and reporting services; Ophthalmological service
Publications
History of USPTO decisions and trademark events.
29 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
12/19/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/03/2023
PUBO
PUBLISHED FOR OPPOSITION
10/03/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/13/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/31/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
08/31/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
08/31/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
08/31/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
08/31/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/30/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/29/2023
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
08/29/2023
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
06/14/2023
GNFR
FINAL REFUSAL E-MAILED
06/14/2023
CNFR
FINAL REFUSAL WRITTEN
06/14/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/12/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/11/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/11/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/15/2022
GNRT
NON-FINAL ACTION E-MAILED
11/15/2022
CNRT
NON-FINAL ACTION WRITTEN
11/15/2022
DOCK
ASSIGNED TO EXAMINER
11/08/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/01/2022
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
03/01/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/01/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/01/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/02/2022
NWAP
NEW APPLICATION ENTERED
01/31/2022
Continuous trademark protection
Get notified about every new filing that threatens NEUROCLUES or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.